Researchers at UC Santa Cruz have developed a novel serological assay for the detection of antibodies to SARS-CoV-2, the coronavirus that causes COVID-19. Rebecca DuBois, associate professor of ...

A recent study published in the journal of Mayo Clinic Proceedings predicted the seroprevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) natural infection in vaccinated ...

It is estimated that around one in five people infected with SARS-CoV-2 will not show any infection symptoms. Some of these are pre-symptomatic, meaning that the COVID symptoms have yet to manifest, ...

Monoclonal antibodies are commonly utilized as anti-inflammatory, anti-cancer and anti-viral therapeutic agents. The location, extent and rate of internalization into cells are considered to be ...

Researchers have developed a COVID-19 test that pinpoints human antibodies specific to a particular part of the SARS-CoV-2 spike protein. The test can be ramped up to document past and recent COVID-19 ...

A reliable antibody test for COVID-19 is critical to identify any and all individuals who have been infected with SARS-CoV-2, regardless of clinical symptoms. This serological test is urgently needed ...

As the United States and much of the world move toward relaxing shelter-in-place restrictions to let people move about more freely, public health experts hope to rely on antibody tests to determine ...

The relationship between the presence of antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the risk of subsequent reinfection remains unclear. We investigated the ...

The Western blot test is an antibody test that’s done on a blood sample. It’s used to confirm or disprove the results of an earlier test for HIV or Lyme disease. Technological advances have produced ...

Researchers have developed a novel serological assay for the detection of antibodies to SARS-CoV-2, the coronavirus that causes COVID-19. Researchers say the new method is as accurate as the most ...